MAPLE GROVE, Minn. — Upsher-Smith Labs on Monday announced the launch of topiramate extended-release capsules, an authorized generic version of Qudexy XR (topiramate) extended-release capsules. The drug is a once-a-day, broad-spectrum antiepileptic drug that's engineered to provide a smooth pharmacokinetic profile.
Both Qudexy XR and its generic equivalent may be swallowed whole or administered by opening the capsule and sprinkling the contents on a spoonful of soft food, the company said.
“At Upsher-Smith, we are breaking the traditional mold and making a generic equivalent to Qudexy XR available immediately so that clinicians and their patients have faster and more affordable access to our quality extended-release topiramate, which is manufactured using the same materials and process as the brand,” said Mark Evenstad, president and CEO of Upsher-Smith. “This launch reflects our commitment to simplify access to effective treatments and provide quality, high-value products to patients.”.
The branded and generic drug are available in 25-mg, 50-mg, 100-mg, 150-mg and 200-mg dosage strengths.